Materiały źródłowe

• #1 Guillain-Barre syndrome – Symptoms and causes – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/guillain-barre-syndrome/symptoms-causes/syc-20362793

  There’s no known cure for Guillain-Barre syndrome. Several treatment options can ease symptoms and help speed recovery. […] The sooner treatment is started, the better the chance of a complete recovery.

• #2 Guillain-Barré syndrome: a comprehensive review – PubMed

  https://pubmed.ncbi.nlm.nih.gov/38813755/

  Guillain-Barr syndrome (GBS) is a potentially devastating yet treatable disorder. […] Intravenous immunoglobulin and plasma exchange remain the primary modalities of treatment, regardless of the electrophysiological subtype. […] Novel potential therapies for GBS are being explored but none have yet modified clinical practice.

• #3

  https://www.who.int/news-room/fact-sheets/detail/guillain-barr%C3%A9-syndrome

  Guillain-Barr syndrome is potentially life-threatening. People with Guillain-Barr syndrome should be treated and monitored as quickly as possible; some may need intensive care. Treatment includes supportive care and some immunological therapies. […] There is no known cure for GBS, but treatments can help improve symptoms of GBS and shorten its duration. […] Given the autoimmune nature of the disease, its acute phase is typically treated with immunotherapy, such as plasma exchange to remove antibodies from the blood or intravenous immunoglobulin. It is most often beneficial when initiated 7 to 14 days after symptoms appear. […] In cases where muscle weakness persists after the acute phase of the illness, patients may require rehabilitation services to strengthen their muscles and restore movement.

• #4 Guillain-Barre syndrome – Symptoms and causes – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/guillain-barre-syndrome/symptoms-causes/syc-20362793

  There’s no known cure for Guillain-Barre syndrome. Several treatment options can ease symptoms and help speed recovery. […] The sooner treatment is started, the better the chance of a complete recovery.

• #5 Diagnosis and management of Guillain–Barré syndrome in ten steps | Nature Reviews Neurology

  https://www.nature.com/articles/s41582-019-0250-9

  GuillainBarr syndrome (GBS) is a rare, but potentially fatal, immune-mediated disease of the peripheral nerves and nerve roots that is usually triggered by infections. […] To support clinicians, especially in the context of an outbreak, we have developed a globally applicable guideline for the diagnosis and management of GBS. […] The ten steps then cover early recognition and diagnosis of GBS, admission to the intensive care unit, treatment indication and selection, monitoring and treatment of disease progression, prediction of clinical course and outcome, and management of complications and sequelae. […] Intravenous immunoglobulin and plasma exchange are equally effective in treating GBS; no other treatments have been proven to be effective. […] The efficacy of repeat treatment in patients who have shown insufficient clinical response is uncertain; nevertheless, this practice is common in patients who show deterioration after an initial treatment response.

• #6 Treatment guidelines for Guillain–Barré Syndrome

  https://pmc.ncbi.nlm.nih.gov/articles/PMC3152164/

  Patients with GBS who are symptomatic but are able to walk unaided for more than 5 m and who are stable can be managed conservatively at peripheral centers. However, they should be observed for progression of the disease, especially if they are still within the first week of the onset of the disease. […] In the acute phase in bed-bound adult patients require both supportive therapy and immunotherapy can be used taking into consideration the cost factors and the clinical status (staging, complications, and other comorbid conditions) of individual patients. […] Immunotherapy therapy has not reduced the mortality in GBS. Mortality is due to disease-related issues or secondary complications developed in hospital due to prolonged disease course. Meticulous and attentive care of these patients are essential in reducing the mortality. Supportive care consensus guidelines have been published.

• #7 Treatment guidelines for Guillain–Barré Syndrome

  https://pmc.ncbi.nlm.nih.gov/articles/PMC3152164/

  Both plasma exchange and IVIg are effective immunotherapies for adult and pediatric patients with GBS if given during the first few weeks of disease. […] In a meta-analysis of 6 class II trails comparing plasma exchange (PE) to supportive care alone for adults with GBS, it was found that PE reduced the risk of developing respiratory failure. […] The volume of plasma removed and the optimum number of PE has not been established and it varies in different trials, but many physicians use the protocol of North American trial in which a total of 200-250 mL/kg was exchanged over 7-10 days all over the world. […] AAN in 2003 concluded that PE hastens recovery in nonambulant patients who get treatment within 4 weeks of onset, and PE hastens recovery of ambulant patients with GBS who are examined within 2 weeks.

• #8 Diagnosis and management of Guillain–Barré syndrome in ten steps | Nature Reviews Neurology

  https://www.nature.com/articles/s41582-019-0250-9

  GuillainBarr syndrome (GBS) is a rare, but potentially fatal, immune-mediated disease of the peripheral nerves and nerve roots that is usually triggered by infections. […] To support clinicians, especially in the context of an outbreak, we have developed a globally applicable guideline for the diagnosis and management of GBS. […] The ten steps then cover early recognition and diagnosis of GBS, admission to the intensive care unit, treatment indication and selection, monitoring and treatment of disease progression, prediction of clinical course and outcome, and management of complications and sequelae. […] Intravenous immunoglobulin and plasma exchange are equally effective in treating GBS; no other treatments have been proven to be effective. […] The efficacy of repeat treatment in patients who have shown insufficient clinical response is uncertain; nevertheless, this practice is common in patients who show deterioration after an initial treatment response.

• #9 Diagnosis and management of Guillain–Barré syndrome in ten steps | Nature Reviews Neurology

  https://www.nature.com/articles/s41582-019-0250-9

  Immunomodulatory therapy should be started if patients are unable to walk independently for 10m. […] Clinical trials have demonstrated a treatment effect for intravenous immunoglobulin (IVIg) when started within 2 weeks of the onset of weakness and for plasma exchange when started within 4 weeks. […] IVIg (0.4g/kg body weight daily for 5 days) and plasma exchange (200250ml plasma/kg body weight in five sessions) are equally effective treatments for GBS. […] Besides IVIg and plasma exchange, no other procedures or drugs have been proven effective in the treatment of GBS. […] Although corticosteroids would be expected to be beneficial in reducing inflammation and, therefore, disease progression in GBS, eight randomized controlled trials on the efficacy of corticosteroids for GBS showed no significant benefit, and treatment with oral corticosteroids was even shown to have a negative effect on outcome.

• #10 Treatment guidelines for Guillain–Barré Syndrome

  https://pmc.ncbi.nlm.nih.gov/articles/PMC3152164/

  Patients with GBS who are symptomatic but are able to walk unaided for more than 5 m and who are stable can be managed conservatively at peripheral centers. However, they should be observed for progression of the disease, especially if they are still within the first week of the onset of the disease. […] In the acute phase in bed-bound adult patients require both supportive therapy and immunotherapy can be used taking into consideration the cost factors and the clinical status (staging, complications, and other comorbid conditions) of individual patients. […] Immunotherapy therapy has not reduced the mortality in GBS. Mortality is due to disease-related issues or secondary complications developed in hospital due to prolonged disease course. Meticulous and attentive care of these patients are essential in reducing the mortality. Supportive care consensus guidelines have been published.

• #11

  https://journals.lww.com/annalsofian/fulltext/2011/14001/treatment_guidelines_for_guillain_barr__syndrome.19.aspx

  Patients with GBS who are symptomatic but are able to walk unaided for more than 5 m and who are stable can be managed conservatively at peripheral centers. […] In the acute phase in bed-bound adult patients require both supportive therapy and immunotherapy can be used taking into consideration the cost factors and the clinical status (staging, complications, and other comorbid conditions) of individual patients. […] Immunotherapy therapy has not reduced the mortality in GBS. […] Both plasma exchange and IVIg are effective immunotherapies for adult and pediatric patients with GBS if given during the first few weeks of disease. […] In a meta-analysis of 6 class II trails comparing plasma exchange (PE) to supportive care alone for adults with GBS, it was found that PE reduced the risk of developing respiratory failure.

• #12 Guillain-Barre Syndrome Medication: Immunomodulatory Agents, Low Molecular Weight Heparin, Analgesics, Anticonvulsants, Tricyclic Antidepressants

  https://emedicine.medscape.com/article/315632-medication

  IVIG may work via several mechanisms, including the blockage of macrophage receptors, the inhibition of antibody production, the inhibition of complement binding, and the neutralization of pathologic antibodies. […] Pain medications may be required in inpatient and outpatient settings. A tiered pharmacologic approach that starts with nonsteroidal anti-inflammatory drugs (NSAIDs) or acetaminophen, with narcotic agents added as needed, is usually recommended. […] Anticonvulsants may be used to alleviate painful dysesthesias, which frequently accompany peripheral neuropathies. […] Tricyclic antidepressants are effective in painful paresthesias. […] Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barr syndrome. […] Hughes RA, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain-Barr syndrome. Cochrane Database Syst Rev. 2010 Jun 16. CD002063. […] Hughes RA, Swan AV, van Doorn PA. Corticosteroids for Guillain-Barr syndrome. Cochrane Database Syst Rev. 2006 Apr 19. CD001446.

• #13 IVIG Therapy for Guillain-Barre | AmeriPharma™ Specialty

  https://ameripharmaspecialty.com/ivig/exploring-ivig-therapy-for-guillain-barre-syndrome/

  Guillain-Barre is a rare but serious autoimmune condition. It affects the nerves and can sometimes be life-threatening. While no known cure exists, treatments such as IVIG are available for Guillain-Barre disease. […] People can make a full recovery by receiving treatment early. If you’re battling this disease, you might also benefit from treatment with IVIG. […] In the US, two out of every 100,000 people suffer from Guillain-Barre, which can be treated with IVIG therapy. Those who don’t receive treatment, especially older individuals, may need hospitalization. […] The most common treatment for Guillain-Barre syndrome is IVIG or intravenous immunoglobulin therapy. […] Immune globulin injections are solutions containing plasma pooled from donated blood that contains healthy antibodies. While the exact mechanism of action for IVIG is still not well established, scientists suggest that these healthy antibodies modulate a compromised immune system.

• #14 Diagnosis and management of Guillain–Barré syndrome in ten steps | Nature Reviews Neurology

  https://www.nature.com/articles/s41582-019-0250-9

  Immunomodulatory therapy should be started if patients are unable to walk independently for 10m. […] Clinical trials have demonstrated a treatment effect for intravenous immunoglobulin (IVIg) when started within 2 weeks of the onset of weakness and for plasma exchange when started within 4 weeks. […] IVIg (0.4g/kg body weight daily for 5 days) and plasma exchange (200250ml plasma/kg body weight in five sessions) are equally effective treatments for GBS. […] Besides IVIg and plasma exchange, no other procedures or drugs have been proven effective in the treatment of GBS. […] Although corticosteroids would be expected to be beneficial in reducing inflammation and, therefore, disease progression in GBS, eight randomized controlled trials on the efficacy of corticosteroids for GBS showed no significant benefit, and treatment with oral corticosteroids was even shown to have a negative effect on outcome.

• #15 Guillain-Barré Syndrome

  https://www.uspharmacist.com/article/guillain-barre-syndrome

  IVIG, which is easier to administer than plasmapheresis, is associated with fewer complications and is more comfortable for the patient. It is recommended for patients who cannot ambulate without assistance within 2 or 4 weeks of neuropathic symptom onset. […] While oral corticosteroids and IV methylprednisolone were once believed to be useful in the treatment of GBS due to their immune-mediated inflammatory mechanism, they are no longer used because they do not seem to offer any benefit over immunotherapy. Furthermore, there seems to be no added advantage of adding corticosteroids to an IVIG regimen. […] Even though immunotherapy has almost halved the duration of mechanical ventilation, about 25% of all patients with GBS demonstrate respiratory failure requiring ICU admission and invasive mechanical ventilation.

• #16 Treatment guidelines for Guillain–Barré Syndrome

  https://pmc.ncbi.nlm.nih.gov/articles/PMC3152164/

  The first RCT on the use of IVIg was published in 1992, and showed that IVIg is as effective as PE. […] The combination of PE followed by IVIg was not significantly better than PE or IVIg alone. […] In general in patients with renal dysfunction the rate of infusion should be decreased to half of the normal infusion rate. […] These patients are able to walk with some support or no support. A retrospective study showed that these patients often have residual disabilities. RCTs that have assessed the effect of IVIg have not studied the effect in mildly affected patients. […] Some patients with GBS continue to deteriorate after PE or a standard course of IVIg. In these cases, the best option is unknown. […] A study in a small series of patients investigated the effect of a second course of IVIg in severe unresponsive patients with GBS. […] When faced with restrictions in financial resources, especially in developing countries cost-effectiveness of any treatment becomes a major issue in treatment decision making. This is very true in GBS in which the currently approved treatment has shown equal efficacy.

• #17

  https://practicalneurology.com/news/treatment-of-guillain-barre-syndrome-using-a-monoclonal-antibody-therapy-shown-to-be-safe-and-effective/2473926/

  2.5-times more participants who received ANX005 returned to normal health by week 8 compared with placebo (OR, 4.1; 95% CI, 1.422 to 12.04; P=.0092). […] Participants treated with ANX005 had a median 28 fewer days on mechanical ventilation (P=.0356) and walked independently a median of 31 days earlier (P=.0211) than those who received placebo. […] While 35% of ANX005-treated patients experienced transient infusion-related reactions, safety profiles were generally comparable across groups with no impact on mortality or infection rates.

• #18 Guillain-Barre syndrome – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/guillain-barre-syndrome/diagnosis-treatment/drc-20363006

  There’s no cure for Guillain-Barre syndrome. But two types of treatments can speed recovery and reduce symptoms: […] Plasma exchange, also known as plasmapheresis. Plasma is the liquid portion of part of your blood. In a plasma exchange, plasma is removed and separated from your blood cells. The blood cells are then put back into your body, which makes more plasma to replace what was removed. Plasmapheresis may work by ridding plasma of certain antibodies that contribute to the immune system’s attack on the peripheral nerves. […] Immunoglobulin therapy. Immunoglobulin containing healthy antibodies from blood donors is given through a vein. High doses of immunoglobulin can block the damaging antibodies that may contribute to Guillain-Barre syndrome. […] These treatments are equally effective. Mixing them or using one after the other is no more effective than using either method alone.

• #19 Treatment for Guillain-Barré Syndrome | Marler Clark

  https://marlerclark.com/foodborne-illnesses/guillain-barre-syndrome/guillain-barre-treatment

  Patients with Guillain-Barr syndrome have better recovery if they are given one of two treatments to calm their immune system: plasma exchange (also known as plasmapheresis) or intravenous immunoglobulin. Both are equally effective, but intravenous immunoglobulin is easier to give. […] In plasma exchange, blood is removed from the patient with a machine similar to a dialysis machine. The cells in the blood are returned to the patient, but the plasma, or the liquid portion of the blood, is not. The body can quickly replace the plasma that is removed. Plasma exchange may help patients with Guillain-Barr syndrome by removing antibodies or other components in the plasma that injure nerve insulation or nerves. […] In intravenous immunoglobulin therapy, patients are given large doses of antibodies derived from plasma from many different donors. Intravenous immunoglobulin may help patients with Guillain-Barr syndrome by blocking the action of antibodies that can injure nerve insulation or nerves.

• #20 Treatment guidelines for Guillain–Barré Syndrome

  https://pmc.ncbi.nlm.nih.gov/articles/PMC3152164/

  Both plasma exchange and IVIg are effective immunotherapies for adult and pediatric patients with GBS if given during the first few weeks of disease. […] In a meta-analysis of 6 class II trails comparing plasma exchange (PE) to supportive care alone for adults with GBS, it was found that PE reduced the risk of developing respiratory failure. […] The volume of plasma removed and the optimum number of PE has not been established and it varies in different trials, but many physicians use the protocol of North American trial in which a total of 200-250 mL/kg was exchanged over 7-10 days all over the world. […] AAN in 2003 concluded that PE hastens recovery in nonambulant patients who get treatment within 4 weeks of onset, and PE hastens recovery of ambulant patients with GBS who are examined within 2 weeks.

• #21

  https://journals.lww.com/annalsofian/fulltext/2011/14001/treatment_guidelines_for_guillain_barr__syndrome.19.aspx

  The volume of plasma removed and the optimum number of PE has not been established and it varies in different trials, but many physicians use the protocol of North American trial in which a total of 200250 mL/kg was exchanged over 710 days all over the world. […] Continuous flow PE is superior to intermittent flow exchanges. […] AAN in 2003 concluded that PE hastens recovery in nonambulant patients who get treatment within 4 weeks of onset, and PE hastens recovery of ambulant patients with GBS who are examined within 2 weeks. […] The first RCT on the use of IVIg was published in 1992, and showed that IVIg is as effective as PE. […] The combination of PE followed by IVIg was not significantly better than PE or IVIg alone. […] If these criteria are met, there is no doubt that patients with GBS should be treated with IVIg or PE.

• #22 Guillain-Barré Syndrome | Diagnosis & Disease Information

  https://www.pulmonologyadvisor.com/ddi/guillain-barre-syndrome/

  Two interventions commonly used to treat Guillain-Barr syndrome are infusion of IV immunoglobulins (IVIG), and therapeutic plasma exchange (plasmapheresis). In the United States, IVIG (0.4 g/kg/d for 5 days) is the preferred treatment for Guillain-Barr syndrome due to its ease of administration. It is believed to neutralize the antibodies that cause symptoms. Patients who have the largest increases in serum immunoglobulin G levels 2 weeks after IVIG treatment experience more clinical benefit than patients with small increases. […] Plasmapheresis (3 liters per session) is recommended for patients with moderate to severe weakness. This treatment may reduce the need mechanical ventilation in rapidly progressive cases and speed recovery if started within 7 days of the onset of symptoms. Mild symptoms often respond to 2 exchanges, and 4 exchanges is recommended for moderate to severe cases. Benefits are most noticeable if treatment is begun within 2 weeks of disease onset, but plasma exchange is effective up to 30 days after the initial presentation of symptoms.

• #23 Treatment guidelines for Guillain–Barré Syndrome

  https://pmc.ncbi.nlm.nih.gov/articles/PMC3152164/

  The first RCT on the use of IVIg was published in 1992, and showed that IVIg is as effective as PE. […] The combination of PE followed by IVIg was not significantly better than PE or IVIg alone. […] In general in patients with renal dysfunction the rate of infusion should be decreased to half of the normal infusion rate. […] These patients are able to walk with some support or no support. A retrospective study showed that these patients often have residual disabilities. RCTs that have assessed the effect of IVIg have not studied the effect in mildly affected patients. […] Some patients with GBS continue to deteriorate after PE or a standard course of IVIg. In these cases, the best option is unknown. […] A study in a small series of patients investigated the effect of a second course of IVIg in severe unresponsive patients with GBS. […] When faced with restrictions in financial resources, especially in developing countries cost-effectiveness of any treatment becomes a major issue in treatment decision making. This is very true in GBS in which the currently approved treatment has shown equal efficacy.

• #24 Guillain-Barré Syndrome: Symptoms, Vaccine, Treatment & More

  https://www.healthline.com/health/guillain-barre-syndrome

  Theres no cure for the condition, but treatment can help reduce the severity of your symptoms and shorten the duration of the illness. […] The goal of treatment is to lessen the severity of the immune attack and support your body functions, such as lung function, while your nervous system recovers. […] Treatments may include plasmapheresis and intravenous immunoglobulin (IVIG). […] The goal of plasmapheresis is to remove the antibodies attacking the nerves from your blood. […] High doses of immunoglobulin can help block the antibodies causing Guillain-Barr syndrome. […] Plasmapheresis and intravenous immunoglobulin (IVIG) are equally effective. […] You may be given medication to relieve pain and prevent blood clots while youre immobile. […] Youll likely receive occupational and physical therapy too.

• #25 Treatment guidelines for Guillain–Barré Syndrome

  https://pmc.ncbi.nlm.nih.gov/articles/PMC3152164/

  The first RCT on the use of IVIg was published in 1992, and showed that IVIg is as effective as PE. […] The combination of PE followed by IVIg was not significantly better than PE or IVIg alone. […] In general in patients with renal dysfunction the rate of infusion should be decreased to half of the normal infusion rate. […] These patients are able to walk with some support or no support. A retrospective study showed that these patients often have residual disabilities. RCTs that have assessed the effect of IVIg have not studied the effect in mildly affected patients. […] Some patients with GBS continue to deteriorate after PE or a standard course of IVIg. In these cases, the best option is unknown. […] A study in a small series of patients investigated the effect of a second course of IVIg in severe unresponsive patients with GBS. […] When faced with restrictions in financial resources, especially in developing countries cost-effectiveness of any treatment becomes a major issue in treatment decision making. This is very true in GBS in which the currently approved treatment has shown equal efficacy.

• #26 IVIG Therapy for Guillain-Barre | AmeriPharma™ Specialty

  https://ameripharmaspecialty.com/ivig/exploring-ivig-therapy-for-guillain-barre-syndrome/

  They concluded IVIG was as effective as plasmapheresis with fewer complications and should be the first-line therapy for Guillain-Barre syndrome. […] A more recent study in 2021 compared the efficiency of different treatments for GBS. Researchers analyzed 28 trials for this analysis that comprised 2474 subjects and human control groups. […] They found that corticosteroids had no significant effect, while IVIG and plasma exchange were effective for GBS treatment. […] In another review in 2021, scientists went over 12 clinical trials. They found that even in the most severe cases of Guillain-Barre syndrome, IVIG can hasten recovery when administered within two weeks from the onset of the disease. […] They concluded that early detection of Guillain-Barre syndrome and treatment with IVIG improves mobility as measured by The Modified Erasmus GBS Outcome Scale.

• #27 Treatment dilemmas in Guillain-Barré syndrome | Journal of Neurology, Neurosurgery & Psychiatry

  https://jnnp.bmj.com/content/88/4/346

  Current personal view: Patients with mild GBS may have long-term functional impairment, but only a beneficial effect of treatment with PE has been demonstrated (level of evidence: 2). […] Current personal view: Evidence from retrospective studies indicates that typical MFS might require supportive care only because of the relatively benign natural course (level of evidence: 3). […] Current personal view: Although the effect of treatment has not properly been studied in BBE, the clinical severity of BBE in the acute phase and overlap with GBS suggests that treatment with IVIg or PE in the acute phase is justifiable (level of evidence: 4). […] Current personal view: At present there is no evidence that outcome is improved by repeating treatment (either IVIg or PE) or switch to another type of treatment (level of evidence: 2).

• #28

  https://journals.lww.com/annalsofian/fulltext/2011/14001/treatment_guidelines_for_guillain_barr__syndrome.19.aspx

  It should be kept in mind that no RCTs have assessed the effect of PE or IVIg in these mildly affected patients with GBS. […] Patients with more severe or complicated anti-GQIB antibody syndrome, an overlapping GBS, should probably receive immunotherapy. […] Some patients with GBS continue to deteriorate after PE or a standard course of IVIg. […] A longer interval between onset and treatment and longer time to nadir may be associated with a greater chance of relapse. […] When faced with restrictions in financial resources, especially in developing countries cost-effectiveness of any treatment becomes a major issue in treatment decision making. […] The main limitations for use of PE would be availability of the technical expertise and support.

• #29 Treatment dilemmas in Guillain-Barré syndrome | Journal of Neurology, Neurosurgery & Psychiatry

  https://jnnp.bmj.com/content/88/4/346

  Current personal view: Patients with mild GBS may have long-term functional impairment, but only a beneficial effect of treatment with PE has been demonstrated (level of evidence: 2). […] Current personal view: Evidence from retrospective studies indicates that typical MFS might require supportive care only because of the relatively benign natural course (level of evidence: 3). […] Current personal view: Although the effect of treatment has not properly been studied in BBE, the clinical severity of BBE in the acute phase and overlap with GBS suggests that treatment with IVIg or PE in the acute phase is justifiable (level of evidence: 4). […] Current personal view: At present there is no evidence that outcome is improved by repeating treatment (either IVIg or PE) or switch to another type of treatment (level of evidence: 2).

• #30 Diagnosis and management of Guillain–Barré syndrome in ten steps | Nature Reviews Neurology

  https://www.nature.com/articles/s41582-019-0250-9

  For the other clinical variants, no evidence regarding treatment is currently available, although many experts will administer IVIg or plasma exchange. […] Neither IVIg nor plasma exchange is contraindicated during pregnancy. […] There is no indication that it is necessary to deviate from standard adult practice when treating children with GBS. […] Regular assessment is required to monitor disease progression and the occurrence of complications. […] Complications in GBS can cause severe morbidity and death. […] About 40% of patients treated with standard doses of plasma exchange or IVIg do not improve in the first 4 weeks following treatment. […] TRFs are observed in 610% of patients with GBS and are defined as disease progression occurring within 2 months following an initial treatment-induced clinical improvement or stabilization.

• #31 Diagnosis and management of Guillain–Barré syndrome in ten steps | Nature Reviews Neurology

  https://www.nature.com/articles/s41582-019-0250-9

  For the other clinical variants, no evidence regarding treatment is currently available, although many experts will administer IVIg or plasma exchange. […] Neither IVIg nor plasma exchange is contraindicated during pregnancy. […] There is no indication that it is necessary to deviate from standard adult practice when treating children with GBS. […] Regular assessment is required to monitor disease progression and the occurrence of complications. […] Complications in GBS can cause severe morbidity and death. […] About 40% of patients treated with standard doses of plasma exchange or IVIg do not improve in the first 4 weeks following treatment. […] TRFs are observed in 610% of patients with GBS and are defined as disease progression occurring within 2 months following an initial treatment-induced clinical improvement or stabilization.

• #32 Treatment-related fluctuation in Guillain-Barre syndrome – Journal of Neurosciences in Rural Practice

  https://ruralneuropractice.com/treatment-related-fluctuation-in-guillain-barre-syndrome/

  Guillain-Barre syndrome (GBS) is usually a monophasic illness, but relapses due to recurrences and treatment-related fluctuations (TRF) with immunotherapy (immunoglobulins or plasma exchange) do occur. […] TRF is defined as improvement in the GBS disability scale of at least one grade after completion of immunotherapy (immunoglobulin/plasmapharesis) followed by a worsening of the disability scale of at least one grade within the first 2 months after disease onset. […] Treatment with intravenous immunoglobulin was recommenced and continued for 5 days. […] TRF may occur in two circumstances. If therapy is initiated very early when the disease process is active, it will only temporarily arrest the disease process and once treatment is over the disease could recur. […] Immune reactions against target epitopes in Schwann-cell surface membrane or myelin result in acute inflammatory demyelinating polyradiculoneuropathy; reactions against epitopes contained in the axonal membrane cause the acute axonal forms of GBS.

• #33 Treatment guidelines for Guillain–Barré Syndrome

  https://pmc.ncbi.nlm.nih.gov/articles/PMC3152164/

  The first RCT on the use of IVIg was published in 1992, and showed that IVIg is as effective as PE. […] The combination of PE followed by IVIg was not significantly better than PE or IVIg alone. […] In general in patients with renal dysfunction the rate of infusion should be decreased to half of the normal infusion rate. […] These patients are able to walk with some support or no support. A retrospective study showed that these patients often have residual disabilities. RCTs that have assessed the effect of IVIg have not studied the effect in mildly affected patients. […] Some patients with GBS continue to deteriorate after PE or a standard course of IVIg. In these cases, the best option is unknown. […] A study in a small series of patients investigated the effect of a second course of IVIg in severe unresponsive patients with GBS. […] When faced with restrictions in financial resources, especially in developing countries cost-effectiveness of any treatment becomes a major issue in treatment decision making. This is very true in GBS in which the currently approved treatment has shown equal efficacy.

• #34 Treatment for Guillain-Barré Syndrome | Marler Clark

  https://marlerclark.com/foodborne-illnesses/guillain-barre-syndrome/guillain-barre-treatment

  About 10% of patients with Guillain-Barr syndrome will get worse again about three weeks after treatment, but their symptoms are usually not as severe as when they first got sick. Studies are underway to determine the best treatment for these patients who relapse. Some experts recommend repeating the same therapy as the patient was initially given. […] Supportive care is also very important for patients with Guillain-Barr syndrome. Supportive care includes careful monitoring of breathing and swallowing, use of a ventilator (if necessary), and prevention or treatment of complications like pneumonia, blood clots in the veins of the legs, and bed sores. Pain control, and physical and occupational therapy are also critical.

• #35 Treatment dilemmas in Guillain-Barré syndrome | Journal of Neurology, Neurosurgery & Psychiatry

  https://jnnp.bmj.com/content/88/4/346

  Current personal view: Corticosteroids as single-treatment strategy should be avoided (level of evidence: 1). […] Current personal view: We recommend repeating the treatment with IVIg or PE after a TRF, although the effect has not been determined in controlled studies (level of evidence: 4). […] Treatment of GBS is complicated by the limited amount of evidence for the treatment effect in various clinical conditions that may frequently occur in GBS.

• #36

  https://journals.lww.com/annalsofian/fulltext/2011/14001/treatment_guidelines_for_guillain_barr__syndrome.19.aspx

  It should be kept in mind that no RCTs have assessed the effect of PE or IVIg in these mildly affected patients with GBS. […] Patients with more severe or complicated anti-GQIB antibody syndrome, an overlapping GBS, should probably receive immunotherapy. […] Some patients with GBS continue to deteriorate after PE or a standard course of IVIg. […] A longer interval between onset and treatment and longer time to nadir may be associated with a greater chance of relapse. […] When faced with restrictions in financial resources, especially in developing countries cost-effectiveness of any treatment becomes a major issue in treatment decision making. […] The main limitations for use of PE would be availability of the technical expertise and support.

• #37 Diagnosis and management of Guillain–Barré syndrome in ten steps | Nature Reviews Neurology

  https://www.nature.com/articles/s41582-019-0250-9

  Immunomodulatory therapy should be started if patients are unable to walk independently for 10m. […] Clinical trials have demonstrated a treatment effect for intravenous immunoglobulin (IVIg) when started within 2 weeks of the onset of weakness and for plasma exchange when started within 4 weeks. […] IVIg (0.4g/kg body weight daily for 5 days) and plasma exchange (200250ml plasma/kg body weight in five sessions) are equally effective treatments for GBS. […] Besides IVIg and plasma exchange, no other procedures or drugs have been proven effective in the treatment of GBS. […] Although corticosteroids would be expected to be beneficial in reducing inflammation and, therefore, disease progression in GBS, eight randomized controlled trials on the efficacy of corticosteroids for GBS showed no significant benefit, and treatment with oral corticosteroids was even shown to have a negative effect on outcome.

• #38 Guillain-Barré Syndrome: Causes, Symptoms, Treatment

  https://patient.info/doctor/guillain-barre-syndrome-pro

  Management in the acute phase of GBS involves a combination of supportive care, disease-modifying therapy in the form of plasma exchange or intravenous immunoglobulin (IVIG), and preventing and managing complications. […] Plasma exchange: A Cochrane review found significantly greater improvement with plasma exchange than supportive care alone, without a significant increase in serious adverse events. […] Intravenous immunoglobulin: A Cochrane review found evidence that, in severe disease, intravenous immunoglobulin started within two weeks from the onset hastens recovery as much as plasma exchange. […] Corticosteroids: moderate-quality evidence suggests that corticosteroids given alone do not significantly hasten recovery from Guillain-Barr syndrome or affect the long-term outcome; they may even delay recovery.

• #39 Treatment dilemmas in Guillain-Barré syndrome | Journal of Neurology, Neurosurgery & Psychiatry

  https://jnnp.bmj.com/content/88/4/346

  Current personal view: Corticosteroids as single-treatment strategy should be avoided (level of evidence: 1). […] Current personal view: We recommend repeating the treatment with IVIg or PE after a TRF, although the effect has not been determined in controlled studies (level of evidence: 4). […] Treatment of GBS is complicated by the limited amount of evidence for the treatment effect in various clinical conditions that may frequently occur in GBS.

• #40 Guillain-Barré syndrome: a comprehensive review – PubMed

  https://pubmed.ncbi.nlm.nih.gov/38813755/

  Guillain-Barr syndrome (GBS) is a potentially devastating yet treatable disorder. […] Intravenous immunoglobulin and plasma exchange remain the primary modalities of treatment, regardless of the electrophysiological subtype. […] Novel potential therapies for GBS are being explored but none have yet modified clinical practice.

• #41 Newly-Released Treatment for Guillain Barre Syndrome

  https://vaccinelaw.com/newly-released-treatment-for-guillain-barre-syndrome-offers-renewed-hope/

  Currently, doctors in the United States rely on two forms of treatment to combat Guillain Barre Syndrome – plasmapheresis and intravenous immunoglobulin. While both forms of treatment have proven to be effective in accelerating a patient’s recovery, researchers continue to look for new, and less-invasive methods to treat patients with this potentially life-changing disorder. […] Researchers at the University of Glasgow in Scotland say that they may have found the first new treatment for Guillain Barre Syndrome in over 20 years. It comes in the form of Eculizumab, a drug that received FDA-approval in 2007 for treatment of certain autoimmune disorders other than GBS. Eculizumab is what is known as a “complement inhibitor,” meaning that it combats the activation of complements by antigen-associated antibodies. This “complement activation” is believed to play a role in the onset of GBS.

• #42

  https://www.docdconsulting.com/finding-hope-promising-advances-in-the-search-for-a-guillain-barre-cure

  Additionally, these treatments primarily target the immune response and do not address the underlying cause of GBS. […] The search for a cure for Guillain-Barre Syndrome has led to the development of several promising therapies and ongoing clinical trials. One such therapy is the use of monoclonal antibodies that specifically target the immune cells responsible for attacking the nerves. […] Another innovative approach being explored is the use of gene therapy to modify the patient’s immune cells. […] Furthermore, advancements in immunotherapies, such as immune checkpoint inhibitors, are being investigated for their potential in treating GBS. […] Stem cell therapy has emerged as a promising avenue in the search for a cure for Guillain-Barre Syndrome. […] In preclinical studies, stem cell transplantation has shown promising results in promoting nerve regeneration and functional recovery in animal models of GBS.

• #43 Guillain-Barre Syndrome Treatment & Management: Approach Considerations, Prehospital and Emergency Department Care, ICU Treatment

  https://emedicine.medscape.com/article/315632-treatment

  Patients who are diagnosed with GBS should be admitted to a hospital for close monitoring until it has been determined that the course of the disease has reached a plateau or undergone reversal. […] Immunomodulatory treatment has been used to hasten recovery. Intravenous immunoglobulin (IVIG) and plasma exchange have proved equally effective. […] Corticosteroids (oral and intravenous) have not been found to have a clinical benefit in GBS. […] A few studies have investigated other medications to treat GBS; however, the trials have been small and the evidence weak, highlighting the need for further investigation of potential treatment options. […] Good supportive care is critical in the treatment of patients with GBS. […] Approximately one third of patients with GBS require ventilatory support.

• #44 Guillain-Barre Syndrome Treatment & Management: Approach Considerations, Prehospital and Emergency Department Care, ICU Treatment

  https://emedicine.medscape.com/article/315632-treatment

  Patients who are diagnosed with GBS should be admitted to a hospital for close monitoring until it has been determined that the course of the disease has reached a plateau or undergone reversal. […] Immunomodulatory treatment has been used to hasten recovery. Intravenous immunoglobulin (IVIG) and plasma exchange have proved equally effective. […] Corticosteroids (oral and intravenous) have not been found to have a clinical benefit in GBS. […] A few studies have investigated other medications to treat GBS; however, the trials have been small and the evidence weak, highlighting the need for further investigation of potential treatment options. […] Good supportive care is critical in the treatment of patients with GBS. […] Approximately one third of patients with GBS require ventilatory support.

• #45 Guillain-Barré syndrome

  https://www.nhs.uk/conditions/guillain-barre-syndrome/

  If you’ve been diagnosed with Guillain-Barr syndrome, you’ll be treated in hospital straight away. You’ll usually be in hospital for several weeks. Some people may need to stay for several months. […] Your main treatment will be immunotherapy to stop your immune system from attacking your nerves. You’ll either have intravenous immunoglobulin (IVIG) or plasma exchange. […] You’ll also have treatment to help manage your symptoms and monitor your condition. You might need: medicine and compression stockings to reduce the risk of deep vein thrombosis (DVT), if you cannot walk; medicines for pain such as gabapentin, carbamazepine or amitriptyline; to be on a ventilator, if you have severe breathing problems this would be in an intensive care unit (ICU). […] You may be offered: physiotherapy to treat muscle stiffness and help you to move more easily; occupational therapy to help you manage everyday tasks and go back to work. […] Your doctor will check you every few months after you recover. You’ll then have checks once a year, because some people can become unwell again and need more treatment.

• #46 Guillain-Barre Syndrome Treatment & Management: Approach Considerations, Prehospital and Emergency Department Care, ICU Treatment

  https://emedicine.medscape.com/article/315632-treatment

  Patients who are diagnosed with GBS should be admitted to a hospital for close monitoring until it has been determined that the course of the disease has reached a plateau or undergone reversal. […] Immunomodulatory treatment has been used to hasten recovery. Intravenous immunoglobulin (IVIG) and plasma exchange have proved equally effective. […] Corticosteroids (oral and intravenous) have not been found to have a clinical benefit in GBS. […] A few studies have investigated other medications to treat GBS; however, the trials have been small and the evidence weak, highlighting the need for further investigation of potential treatment options. […] Good supportive care is critical in the treatment of patients with GBS. […] Approximately one third of patients with GBS require ventilatory support.

• #47 Diagnosis and management of Guillain–Barré syndrome in ten steps | Nature Reviews Neurology

  https://www.nature.com/articles/s41582-019-0250-9

  For the other clinical variants, no evidence regarding treatment is currently available, although many experts will administer IVIg or plasma exchange. […] Neither IVIg nor plasma exchange is contraindicated during pregnancy. […] There is no indication that it is necessary to deviate from standard adult practice when treating children with GBS. […] Regular assessment is required to monitor disease progression and the occurrence of complications. […] Complications in GBS can cause severe morbidity and death. […] About 40% of patients treated with standard doses of plasma exchange or IVIg do not improve in the first 4 weeks following treatment. […] TRFs are observed in 610% of patients with GBS and are defined as disease progression occurring within 2 months following an initial treatment-induced clinical improvement or stabilization.

• #48 Guillain-Barré Syndrome vs. MS | Mass General Brigham

  https://www.massgeneralbrigham.org/en/about/newsroom/articles/ms-vs-guillain-barre-syndrome

  Guillain-Barr syndrome is a rare condition that develops after a person’s immune system fights off an actual infection. […] While there’s no cure for Guillain-Barr syndrome, there are treatment options that can relieve symptoms and shorten recovery time. These include: […] Plasma exchange (PE): A health care provider draws a patient’s blood and uses a machine to separate the liquid form of the blood (plasma) from the red blood cells. […] Intravenous immunoglobulin therapy (IVIg): A healthcare provider uses an IV or injection to deliver plasma containing immunoglobulin, a protein the immune system produces to fight infection, to a patient’s bloodstream. […] Hospitalization: Some patients may need care in a hospital if they experience breathing difficulties, abnormal heart rates, or paralysis.

• #49 Guillain-Barre Syndrome Treatment & Management: Approach Considerations, Prehospital and Emergency Department Care, ICU Treatment

  https://emedicine.medscape.com/article/315632-treatment

  Pain medications may be required in inpatient and outpatient settings. A tiered pharmacologic approach that starts with nonsteroidal anti-inflammatory drugs (NSAIDs) or acetaminophen, with narcotic agents added as needed, is usually recommended. […] Immune adsorption is an alternative treatment for Guillain-Barr syndrome that is still being investigated. […] Venous thromboembolism is one of the major sequelae of extremity paralysis. […] Consultation with a neurologist can be helpful in the initial diagnosis, workup, and treatment of patients admitted to the medical floor with GBS. […] Although follow-up studies generally have assessed patients 6-12 months after onset of GBS, some studies have reported continued improvements in strength even beyond 2 years.

• #50 Guillain-Barré Syndrome

  https://www.uspharmacist.com/article/guillain-barre-syndrome

  Pain remains an undertreated but important aspect of GBS. Furthermore, patients who are immobilized and require tracheal intubation are not able to effectively express the extent of pain experienced. A pain management regimen should therefore be considered in all patients presenting with GBS. […] Anticonvulsants are frequently used in the management of neuropathic pain associated with GBS. Small trials have shown a positive analgesic effect with gabapentin or carbamazepine for pain management in GBS. […] Physical therapy involving gentle massage, passive range of motion exercises, and frequent position changes may provide adjuvant relief in some patients. This may be integrated together with a rehabilitation program including occupational and physical therapy to overcome the persistent fatigue that is experienced due to the loss of axons.

• #51 Guillain-Barre Syndrome Treatment & Management: Approach Considerations, Prehospital and Emergency Department Care, ICU Treatment

  https://emedicine.medscape.com/article/315632-treatment

  Pain medications may be required in inpatient and outpatient settings. A tiered pharmacologic approach that starts with nonsteroidal anti-inflammatory drugs (NSAIDs) or acetaminophen, with narcotic agents added as needed, is usually recommended. […] Immune adsorption is an alternative treatment for Guillain-Barr syndrome that is still being investigated. […] Venous thromboembolism is one of the major sequelae of extremity paralysis. […] Consultation with a neurologist can be helpful in the initial diagnosis, workup, and treatment of patients admitted to the medical floor with GBS. […] Although follow-up studies generally have assessed patients 6-12 months after onset of GBS, some studies have reported continued improvements in strength even beyond 2 years.

• #52 Guillain-Barré Syndrome

  https://www.uspharmacist.com/article/guillain-barre-syndrome

  Pain remains an undertreated but important aspect of GBS. Furthermore, patients who are immobilized and require tracheal intubation are not able to effectively express the extent of pain experienced. A pain management regimen should therefore be considered in all patients presenting with GBS. […] Anticonvulsants are frequently used in the management of neuropathic pain associated with GBS. Small trials have shown a positive analgesic effect with gabapentin or carbamazepine for pain management in GBS. […] Physical therapy involving gentle massage, passive range of motion exercises, and frequent position changes may provide adjuvant relief in some patients. This may be integrated together with a rehabilitation program including occupational and physical therapy to overcome the persistent fatigue that is experienced due to the loss of axons.

• #53 Guillain-Barré Syndrome | Diagnosis & Disease Information

  https://www.pulmonologyadvisor.com/ddi/guillain-barre-syndrome/

  Both plasmapheresis and IVIG may reduce the time it takes to recover by as much as 50%, but there is no additional benefit from combining the 2 treatments. Treatment with corticosteroids is not recommended. […] In 2023, the European Academy of Neurology/Peripheral Nerve Society (EAN/PNS) published a Guideline on the diagnosis and treatment of Guillain-Barr syndrome. According to the Task Force that created the EAN/PNS Guideline, the recommended treatment for patients who are unable to walk without assistance is IVIG (0.4g/kg for 5days) within 2weeks after onset of weakness, or a course of plasma exchange (12 to 15L in 4 to 5 exchanges over 1 to 2weeks) in patients within 4weeks after onset of weakness. […] The EAN/PNS Task Force also recommended against a second IVIG course in patients with a poor prognosis; recommended against using oral corticosteroids; weakly recommended against using IV corticosteroids; did not recommend plasma exchange followed immediately by IVIG; weakly recommended gabapentinoids, tricyclic antidepressants, or carbamazepine for treatment of pain; and did not recommend a specific treatment for fatigue.

• #54 Guillain-Barré Syndrome

  https://www.uspharmacist.com/article/guillain-barre-syndrome

  Pain remains an undertreated but important aspect of GBS. Furthermore, patients who are immobilized and require tracheal intubation are not able to effectively express the extent of pain experienced. A pain management regimen should therefore be considered in all patients presenting with GBS. […] Anticonvulsants are frequently used in the management of neuropathic pain associated with GBS. Small trials have shown a positive analgesic effect with gabapentin or carbamazepine for pain management in GBS. […] Physical therapy involving gentle massage, passive range of motion exercises, and frequent position changes may provide adjuvant relief in some patients. This may be integrated together with a rehabilitation program including occupational and physical therapy to overcome the persistent fatigue that is experienced due to the loss of axons.

• #55 Guillain-Barre Syndrome Treatment & Management: Approach Considerations, Prehospital and Emergency Department Care, ICU Treatment

  https://emedicine.medscape.com/article/315632-treatment

  Pain medications may be required in inpatient and outpatient settings. A tiered pharmacologic approach that starts with nonsteroidal anti-inflammatory drugs (NSAIDs) or acetaminophen, with narcotic agents added as needed, is usually recommended. […] Immune adsorption is an alternative treatment for Guillain-Barr syndrome that is still being investigated. […] Venous thromboembolism is one of the major sequelae of extremity paralysis. […] Consultation with a neurologist can be helpful in the initial diagnosis, workup, and treatment of patients admitted to the medical floor with GBS. […] Although follow-up studies generally have assessed patients 6-12 months after onset of GBS, some studies have reported continued improvements in strength even beyond 2 years.

• #56 Guillain-Barré Syndrome: Causes, Symptoms, Treatment

  https://patient.info/doctor/guillain-barre-syndrome-pro

  Deep vein thrombosis (DVT) prophylaxis: DVT due to immobility should be prevented with gradient compression stockings and subcutaneous low molecular weight heparin. […] Admission to the intensive care unit (ICU): intubation and assisted ventilation may be required. […] Pain relief: may be required for neuropathic pain.

• #57 Guillain-Barré Syndrome Rehabilitation | Memorial Hermann

  https://memorialhermann.org/services/treatments/guillain-barre-syndrome-rehabilitation

  While there is no known cure for Guillain-Barré Syndrome (GBS), certain therapies can lessen the severity of the illness and expedite recovery. Plasma exchange (also called plasmapheresis, in which whole blood is removed from the body and processed to remove the plasma, followed by reintroduction of the red and white blood cells into the body) and high-dose immunoglobulin therapy are used to reduce the severity and duration of the GBS episode. […] The most critical part of treatment for GBS involves keeping the patient’s body functioning during recovery of the nervous system. This can require placing the patient on mechanical ventilatory assistance, a heart monitor or other machines to aid bodily functions. Physical, occupational and speech therapies play an important role, both before and after recovery begins.

• #58 Treatment of Guillain-Barré syndrome in German clinics | Booking Health

  https://bookinghealth.com/diseases/guillain-barre-syndrome

  Guillain-Barr syndrome Treatment […] The conservative treatment and emergency resuscitation are applied in the case of Guillain-Barr syndrome. The rehabilitation is also used to restore the patient after treatment. […] Conservative therapy is directed at the following options: Blocking of the autoimmune inflammatory process, Maintaining of the patients vital functions, Elimination or reduction of the main symptoms. […] Intravenous immunoglobulin G injections or plasmapheresis are used to reduce the manifestations of the autoimmune process. These techniques are indicated if a patient has movement disorders of stage 4 or 5. […] Following procedures might be required to support the patients vital activities: Artificial lung ventilation is commonly applied for several days or weeks, rarely for more than a month. If ALV is provided for more than 10 days, than a tracheostomy (a tube is inserted directly into the trachea through an incision in the neck and lets the oxygen to flow through) is required. Implantation of an artificial pacemaker is necessary for treatment of severe brady-arrhythmias, when there is a risk of circulatory failure. Gastrostomy tube placement is required to deal with bulbar disorders when a patient is unable to eat on his own and the food is introduced directly into the stomach. […] Symptomatic therapy includes use of the medicines for the intravenous infusion, lowering the blood pressure, and controlling the heart rate frequency. Pain is reduced with painkillers. Bacterial infectious complications are treated with the antibiotics and other medicines, depending on the certain clinical case.

• #59 Guillain-Barré syndrome – UF Health

  https://ufhealth.org/conditions-and-treatments/guillain-barr%C3%A9-syndrome

  While there is no cure for GBS, most people will notice improvement within days to weeks. Treatment is aimed at reducing symptoms, treating complications, and speeding up recovery. […] In the early stages of the illness, a treatment called apheresis or plasmapheresis may be given. It involves removing the proteins, called antibodies, which attack the nerve cells. Another treatment is intravenous immunoglobulin (IVIg). Both treatments lead to faster improvement, and both are equally effective. But there is no advantage to using both treatments at the same time. Other treatments help reduce inflammation. […] When symptoms are severe, treatment in the hospital will be needed. Breathing support will likely be given. […] Other treatments in the hospital focus on preventing complications. These may include: Blood thinners to prevent blood clots, Breathing support or a breathing tube and ventilator, if the diaphragm is weak, Pain medicines or other medicines to treat pain, Proper body positioning or a feeding tube to prevent choking during feeding, if the muscles used for swallowing are weak, Physical therapy to help keep joints and muscles healthy.

• #60 Treatment of Guillain-Barré syndrome in German clinics | Booking Health

  https://bookinghealth.com/diseases/guillain-barre-syndrome

  Guillain-Barr syndrome Treatment […] The conservative treatment and emergency resuscitation are applied in the case of Guillain-Barr syndrome. The rehabilitation is also used to restore the patient after treatment. […] Conservative therapy is directed at the following options: Blocking of the autoimmune inflammatory process, Maintaining of the patients vital functions, Elimination or reduction of the main symptoms. […] Intravenous immunoglobulin G injections or plasmapheresis are used to reduce the manifestations of the autoimmune process. These techniques are indicated if a patient has movement disorders of stage 4 or 5. […] Following procedures might be required to support the patients vital activities: Artificial lung ventilation is commonly applied for several days or weeks, rarely for more than a month. If ALV is provided for more than 10 days, than a tracheostomy (a tube is inserted directly into the trachea through an incision in the neck and lets the oxygen to flow through) is required. Implantation of an artificial pacemaker is necessary for treatment of severe brady-arrhythmias, when there is a risk of circulatory failure. Gastrostomy tube placement is required to deal with bulbar disorders when a patient is unable to eat on his own and the food is introduced directly into the stomach. […] Symptomatic therapy includes use of the medicines for the intravenous infusion, lowering the blood pressure, and controlling the heart rate frequency. Pain is reduced with painkillers. Bacterial infectious complications are treated with the antibiotics and other medicines, depending on the certain clinical case.

• #61 Guillain-Barre Syndrome + 4 Ways to Manage Symptoms – Dr. Axe

  https://draxe.com/health/guillain-barre-syndrome/

  Plasmapheresis This is a type of blood cleansing procedure, also called a plasma exchange, in which antibodies are removed from the blood in order to reduce hyperactivity of the immune system. […] Physical therapy and medications to manage pain may also be used, depending on the patients symptoms. […] Physical therapy is usually recommended to help regain strength, muscle control, good posture and flexibility. […] Natural painkillers may help, including: […] Pain treatment depends on the presence and severity of symptoms. […] Nutritional support should begin as quickly as possible. […] GBS is usually conventionally treated with intravenous immunoglobulin (administering healthy antibodies), plasmapheresis to help cleanse the blood, physical therapy, pain management and nutritional support. […] 4 Natural Ways to Support Guillain-Barre Syndrome Recovery: Physical therapy/movement, Natural pain killers for mild-to-moderate pain, including lavender and peppermint essential oils and acupuncture, Treating constipation and GI issues, Supporting heart health to prevent complications.

• #62 After the Hospital, A Guide to Rehabilitation for GBS – GBS/CIDP Foundation International

  https://www.gbs-cidp.org/after-the-hospital-a-guide-to-rehabilitation-for-gbs/

  The rehabilitation process itself does not improve nerve regeneration. Rather, the major goal of rehabilitation is to assist the patient in optimal use of muscles as their nerve supply returns, and to adapt to a lifestyle within their functional limitations. […] Rehabilitation in many centers is accomplished by the coordinated efforts of several groups of professionals in a team approach. […] The physiatrist (pronounced: fiz-eye’-a-trist) (not to be confused with a psychiatrist) is a physician who specializes in physical medicine and rehabilitation. A physiatrist usually coordinates and oversees the total rehabilitation program. […] During the rehabilitation process, certain issues are unique to GBS patients. […] The physical therapist emphasizes strength and function of the lower limbs, and ultimately teaches the patient to walk as independently as possible.

• #63 Guide | Physical Therapy Guide to Guillain-Barré Syndrome | Choose PT

  https://www.choosept.com/guide/physical-therapy-guide-guillain-barre-syndrome

  Physical therapists have extensive training to help people during GBS recovery. They help patients understand how GBS affects their ability to move safely, and how to reduce their risk for falls. Physical therapists design personalized treatment plans so people with GBS can: […] Physical therapy for people with GBS typically begins in the hospital. It may continue at an inpatient rehabilitation facility, outpatient clinic, or both. […] Physical therapy treatment for people with GBS should begin as soon as possible following diagnosis. It likely will begin in the hospital and span several settings. Physical therapists may treat you in: […] Physical therapists can provide a variety of treatments to address the symptoms of GBS. These will include activities to improve function and patient education. They will work with you to set goals based on your needs and how you are progressing.

• #64 Guillain-Barre Syndrome (GBS) Symptoms, Treatment & Diagnosis

  https://www.emedicinehealth.com/guillain-barre_syndrome/article_em.htm

  Other Therapy for Guillain-Barr Syndrome Physical therapy should be started as soon as the person can tolerate the activity. Physical therapy should include heat, which provides pain relief. The person should do range-of-motion exercises to prevent joint and muscle stiffness. […] Guillain-Barr Syndrome Outlook A majority of people with Guillain-Barr syndrome will make a complete recovery. Symptoms will gradually improve over several months. Any lasting problems may be addressed through additional physical therapy. Some people might need orthopedic devices to assist with activities of daily living. Some people are at risk for relapsing. They will develop chronic neuropathy (nerve problems). For these people, drugs that suppress the immune system and plasmapheresis may be helpful.

• #65 Guillain Barre Syndrome

  https://www.physio.co.uk/what-we-treat/neurological/conditions/guillain-barre-syndrome.php

  Physiotherapy treatment will promote recovery and help people with Guilian-Barre syndrome keep their work, home and social life as active as possible. […] Physiotherapy will help speed up recovery. […] Physiotherapy treatment aims to accelerate your recovery and lessen the severity of your condition. […] Physiotherapy should be started as soon as possible. […] Physiotherapy treatment for Guillain-Barr syndrome should start in hospital and continue until you have reached your maximum potential. […] Physiotherapy for Guillain-Barr syndrome will: Increase muscle strength, Increase mobility, Increase balance, Retrain normal patterns of movement, Increase fitness and energy levels, Improving posture when sitting, standing and sleeping, Increased ability to relax, Minimise secondary complications such as muscle contractures and chest infections, Promote recovery.

• #66 Guillain Barre Syndrome

  https://www.physio.co.uk/what-we-treat/neurological/conditions/guillain-barre-syndrome.php

  Our motivated physiotherapists will help improve your energy levels and sense of well being. […] The exercise program will depend on your individual needs and will be centred around: Teaching exercises to strengthen your muscles using them correctly as often as possible, Exercises to improve posture and balance in sitting and standing promoting everyday tasks and independence, Stretching to lengthen tight muscles, Exercises to increase your stamina and reducing fatigue, Exercises to enhance functional abilities, Breathing control and assisted coughing if appropriate to maintain a clear chest, Hydrotherapy treatment to relax muscles and improve walking.

• #67 Guillain-Barré Syndrome (GBS): Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/15838-guillain-barre-syndrome

  As you begin to improve, your healthcare team may transfer you to a rehabilitation setting. Here, youll work with physical therapists and other therapists to regain strength and resume activities of daily living. Types of therapy include: […] Physical therapy: This helps you improve how your body moves. A physical therapist will help you manage symptoms like pain, stiffness and discomfort. […] Occupational therapy: This type of therapy helps you improve your ability to do daily tasks. […] Speech therapy: If GBS affects the muscles in your mouth or throat, a speech-language pathologist can help you regain skills of swallowing and speaking. […] The good news is that most people with GBS recover well with treatment.

• #68

  https://www.aurorahealthcare.org/services/neuroscience/neurology/neurological-conditions/neuromuscular-disorders/guillain-barre

  Intravenous immune globulin (IVIG) infusion: In this approach, immunoglobulins (antibodies) are extracted from the donated plasma of many individuals and then injected into your bloodstream. This acts to dilute the antibodies that are attacking your nerves with healthy antibodies. […] Most people fully recover within a few months to a few years. Rehabilitation and physical therapy treatments are crucial for regaining strength and addressing lingering weakness and fatigue. […] Occupational therapy and vocational therapy can help you learn new ways to handle daily activities.

• #69 After the Hospital, A Guide to Rehabilitation for GBS – GBS/CIDP Foundation International

  https://www.gbs-cidp.org/after-the-hospital-a-guide-to-rehabilitation-for-gbs/

  As nerve innervation returns, other exercises can be used to maintain muscle strength. […] For patients with persisting muscle group weakness, various methods (orthotic devices) can be used to increase function and independence. […] A speech therapist can help the patient learn exercises for the affected muscles, to improve speech patterns and clarity of voice, as well as recommend dietary changes to facilitate safe swallowing with adequate nutrition. […] The majority of patients who were in a rehabilitation center may be placed on an out-patient therapy program when sufficient strength has returned. […] After discharge from a formal hospital-based in or out-patient rehabilitation program, there is often a role for continued exercise. […] Each recovering patient should be evaluated for their individual needs.

• #70 Guillain-Barré Syndrome (GBS): Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/15838-guillain-barre-syndrome

  As you begin to improve, your healthcare team may transfer you to a rehabilitation setting. Here, youll work with physical therapists and other therapists to regain strength and resume activities of daily living. Types of therapy include: […] Physical therapy: This helps you improve how your body moves. A physical therapist will help you manage symptoms like pain, stiffness and discomfort. […] Occupational therapy: This type of therapy helps you improve your ability to do daily tasks. […] Speech therapy: If GBS affects the muscles in your mouth or throat, a speech-language pathologist can help you regain skills of swallowing and speaking. […] The good news is that most people with GBS recover well with treatment.

• #71 After the Hospital, A Guide to Rehabilitation for GBS – GBS/CIDP Foundation International

  https://www.gbs-cidp.org/after-the-hospital-a-guide-to-rehabilitation-for-gbs/

  As nerve innervation returns, other exercises can be used to maintain muscle strength. […] For patients with persisting muscle group weakness, various methods (orthotic devices) can be used to increase function and independence. […] A speech therapist can help the patient learn exercises for the affected muscles, to improve speech patterns and clarity of voice, as well as recommend dietary changes to facilitate safe swallowing with adequate nutrition. […] The majority of patients who were in a rehabilitation center may be placed on an out-patient therapy program when sufficient strength has returned. […] After discharge from a formal hospital-based in or out-patient rehabilitation program, there is often a role for continued exercise. […] Each recovering patient should be evaluated for their individual needs.

• #72 After the Hospital, A Guide to Rehabilitation for GBS – GBS/CIDP Foundation International

  https://www.gbs-cidp.org/after-the-hospital-a-guide-to-rehabilitation-for-gbs/

  The rehabilitation process itself does not improve nerve regeneration. Rather, the major goal of rehabilitation is to assist the patient in optimal use of muscles as their nerve supply returns, and to adapt to a lifestyle within their functional limitations. […] Rehabilitation in many centers is accomplished by the coordinated efforts of several groups of professionals in a team approach. […] The physiatrist (pronounced: fiz-eye’-a-trist) (not to be confused with a psychiatrist) is a physician who specializes in physical medicine and rehabilitation. A physiatrist usually coordinates and oversees the total rehabilitation program. […] During the rehabilitation process, certain issues are unique to GBS patients. […] The physical therapist emphasizes strength and function of the lower limbs, and ultimately teaches the patient to walk as independently as possible.

• #73 Guillain–Barré syndrome – Wikipedia

  https://en.wikipedia.org/wiki/Guillain%E2%80%93Barr%C3%A9_syndrome

  Following the acute phase, around 40% of people require intensive rehabilitation with the help of a multidisciplinary team to focus on improving activities of daily living (ADLs). Studies into the subject have been limited, but it is likely that intensive rehabilitation improves long-term symptoms. Teams may include physical therapists, occupational therapists, speech language pathologists, social workers, psychologists, other allied health professionals and nurses. The team usually works under the supervision of a neurologist or rehabilitation physician directing treatment goals. […] Ongoing specialist community support, information, advice, and guidance is available from a range of Charities, Non-Government Organisations (NGOs), and Patient Advisory Groups around the world. In the United Kingdom this is provided by GAIN (GuillainBarr and Associated Inflammatory Neuropathies), in the USA it is provided by GBS/CIDP Foundation International, and in The European Union by a range of organisations under the umbrella of EPODIN (European Patient Organization for Disimmune Inflammatory Neuropathies).

• #74 After the Hospital, A Guide to Rehabilitation for GBS – GBS/CIDP Foundation International

  https://www.gbs-cidp.org/after-the-hospital-a-guide-to-rehabilitation-for-gbs/

  The progression of disability during the acute phase of Guillain-Barré Syndrome can vary from a few days to four weeks, and, infrequently, six weeks. […] However, many patients will still require rehabilitative care including intensive physical and occupational therapy. […] Choices available for further rehabilitation include: In-patient care in a rehabilitation hospital. A common requirement to justify this intensive rehabilitation is the patient’s ability to participate in at least 3 hours of therapy daily. […] The decision as to the type and location for rehabilitation should be individualized to each patient’s particular needs, considering factors such as overall physical condition, strength, endurance, amount of return of use of arms and legs, and insurance. […] Regardless, transfer of a patient to a rehabilitation center should be considered as a positive next step in the patient’s recovery.

• #75 After the Hospital, A Guide to Rehabilitation for GBS – GBS/CIDP Foundation International

  https://www.gbs-cidp.org/after-the-hospital-a-guide-to-rehabilitation-for-gbs/

  As nerve innervation returns, other exercises can be used to maintain muscle strength. […] For patients with persisting muscle group weakness, various methods (orthotic devices) can be used to increase function and independence. […] A speech therapist can help the patient learn exercises for the affected muscles, to improve speech patterns and clarity of voice, as well as recommend dietary changes to facilitate safe swallowing with adequate nutrition. […] The majority of patients who were in a rehabilitation center may be placed on an out-patient therapy program when sufficient strength has returned. […] After discharge from a formal hospital-based in or out-patient rehabilitation program, there is often a role for continued exercise. […] Each recovering patient should be evaluated for their individual needs.

• #76 Diagnosis and management of Guillain–Barré syndrome in ten steps | Nature Reviews Neurology

  https://www.nature.com/articles/s41582-019-0250-9

  Most patients with GBS, even those who were tetraplegic at nadir or required mechanical ventilation for a long period of time, show extensive recovery, especially in the first year after disease onset. […] Patients with GBS can experience a range of long-term residual problems, including incomplete recovery of motor and sensory function, as well as fatigue, pain and psychological distress. […] Arranging a rehabilitation programme with a rehabilitation specialist, physiotherapist and occupational therapist is a crucial step towards recovery.

• #77 Guillain-Barré Syndrome: Causes, Symptoms, and Treatment

  https://www.webmd.com/brain/what-is-guillain-barre

  Among adults with the condition: […] About 80% can walk without help after 6 months. […] About 60% fully recover muscle strength within 1 year. […] About 5%-10% have a very delayed and incomplete recovery. […] Children rarely get GBS, but when they do, they usually recover more quickly than adults.

• #78 Diagnosis and Treatment of Guillain-Barre Syndrome | Journal of Ethics | American Medical Association

  https://journalofethics.ama-assn.org/article/diagnosis-and-treatment-guillain-barre-syndrome/2007-08

  GBS requires hospitalization for supportive care and for close monitoring of respiratory function and signs of dysautonomy. Intravenous immunoglobulin G therapy and plasma exchange have been shown to be effective in AIDP. Use of steroids is not indicated. […] The majority of patients begin to recover after two to four weeks from onset of symptoms. About 85 percent return to baseline within one year, and about 5-10 percent have remaining disabling motor and sensory deficits. GBS mortality, estimated at about 5 percent, results from respiratory distress syndrome, aspiration pneumonia, sepsis, pulmonary embolism, and arrhythmias. Relapse of disease may occur months to years from the first episode in 2-3 percent of patients.

• #79 Guillain-Barré syndrome

  https://www.nhs.uk/conditions/guillain-barre-syndrome/

  If you’ve been diagnosed with Guillain-Barr syndrome, you’ll be treated in hospital straight away. You’ll usually be in hospital for several weeks. Some people may need to stay for several months. […] Your main treatment will be immunotherapy to stop your immune system from attacking your nerves. You’ll either have intravenous immunoglobulin (IVIG) or plasma exchange. […] You’ll also have treatment to help manage your symptoms and monitor your condition. You might need: medicine and compression stockings to reduce the risk of deep vein thrombosis (DVT), if you cannot walk; medicines for pain such as gabapentin, carbamazepine or amitriptyline; to be on a ventilator, if you have severe breathing problems this would be in an intensive care unit (ICU). […] You may be offered: physiotherapy to treat muscle stiffness and help you to move more easily; occupational therapy to help you manage everyday tasks and go back to work. […] Your doctor will check you every few months after you recover. You’ll then have checks once a year, because some people can become unwell again and need more treatment.

• #80 After the Hospital, A Guide to Rehabilitation for GBS – GBS/CIDP Foundation International

  https://www.gbs-cidp.org/after-the-hospital-a-guide-to-rehabilitation-for-gbs/

  Fatigue is a common problem during the early part of recovery and can even persist in some patients who appear to have recovered. […] The overall outlook for most GBS patients is good, but the course of the illness can be quite variable. […] A full recovery can be expected, eventually. […] At least 20% of patients have significant residual symptoms and these patients benefit the most from treatment intervention to modify the immune system. […] Since GBS rarely strikes twice, if, after recovery, a patient again develops abnormal sensations, it is usually appropriate to look for causes other than Guillain-Barré Syndrome.

• #81 Diagnosis and Treatment of Guillain-Barre Syndrome | Journal of Ethics | American Medical Association

  https://journalofethics.ama-assn.org/article/diagnosis-and-treatment-guillain-barre-syndrome/2007-08

  GBS requires hospitalization for supportive care and for close monitoring of respiratory function and signs of dysautonomy. Intravenous immunoglobulin G therapy and plasma exchange have been shown to be effective in AIDP. Use of steroids is not indicated. […] The majority of patients begin to recover after two to four weeks from onset of symptoms. About 85 percent return to baseline within one year, and about 5-10 percent have remaining disabling motor and sensory deficits. GBS mortality, estimated at about 5 percent, results from respiratory distress syndrome, aspiration pneumonia, sepsis, pulmonary embolism, and arrhythmias. Relapse of disease may occur months to years from the first episode in 2-3 percent of patients.

• #82 Diagnosis and management of Guillain–Barré syndrome in ten steps | Nature Reviews Neurology

  https://www.nature.com/articles/s41582-019-0250-9

  Most patients with GBS, even those who were tetraplegic at nadir or required mechanical ventilation for a long period of time, show extensive recovery, especially in the first year after disease onset. […] Patients with GBS can experience a range of long-term residual problems, including incomplete recovery of motor and sensory function, as well as fatigue, pain and psychological distress. […] Arranging a rehabilitation programme with a rehabilitation specialist, physiotherapist and occupational therapist is a crucial step towards recovery.

• #83 After the Hospital, A Guide to Rehabilitation for GBS – GBS/CIDP Foundation International

  https://www.gbs-cidp.org/after-the-hospital-a-guide-to-rehabilitation-for-gbs/

  Fatigue is a common problem during the early part of recovery and can even persist in some patients who appear to have recovered. […] The overall outlook for most GBS patients is good, but the course of the illness can be quite variable. […] A full recovery can be expected, eventually. […] At least 20% of patients have significant residual symptoms and these patients benefit the most from treatment intervention to modify the immune system. […] Since GBS rarely strikes twice, if, after recovery, a patient again develops abnormal sensations, it is usually appropriate to look for causes other than Guillain-Barré Syndrome.

• #84 Diagnosis and management of Guillain–Barré syndrome in ten steps | Nature Reviews Neurology

  https://www.nature.com/articles/s41582-019-0250-9

  Most patients with GBS, even those who were tetraplegic at nadir or required mechanical ventilation for a long period of time, show extensive recovery, especially in the first year after disease onset. […] Patients with GBS can experience a range of long-term residual problems, including incomplete recovery of motor and sensory function, as well as fatigue, pain and psychological distress. […] Arranging a rehabilitation programme with a rehabilitation specialist, physiotherapist and occupational therapist is a crucial step towards recovery.

• #85 Understanding Guillain-Barre Syndrome (GBS): Causes, Symptoms, and Treatment Options

  https://www.artemishospitals.com/blog/articles-by-doctors/understanding-guillain-barre-syndrome-gbs-causes-symptoms-and-treatment-options

  GBS is curable and early medical treatment results in complete or partial recovery. Treatment primarily focuses on immune system modulation and supportive care to prevent complications. It should be started as early as within two weeks or better outcomes depending upon the severity of the disease. […] A procedure that removes harmful antibodies from the blood, preventing further nerve damage. […] Involves administering high doses of immunoglobulins to neutralize the free antibodies which are causing the immune attack on nerves. […] Both plasmapheresis and IVIG are not used together, as they do not enhance recovery when combined. Either of the two should be started as early as possible. […] Since GBS can lead to temporary and reversible paralysis and breathing difficulties, patients often require intensive supportive care: […] Physiotherapy and Occupational Therapy Helps in regaining muscle strength, coordination, and mobility. […] With timely treatment and proper rehabilitation, most people with GBS recover fully or regain significant function, though recovery can take weeks to years.

• #86 Diagnosis and management of Guillain–Barré syndrome in ten steps | Nature Reviews Neurology

  https://www.nature.com/articles/s41582-019-0250-9

  GuillainBarr syndrome (GBS) is a rare, but potentially fatal, immune-mediated disease of the peripheral nerves and nerve roots that is usually triggered by infections. […] To support clinicians, especially in the context of an outbreak, we have developed a globally applicable guideline for the diagnosis and management of GBS. […] The ten steps then cover early recognition and diagnosis of GBS, admission to the intensive care unit, treatment indication and selection, monitoring and treatment of disease progression, prediction of clinical course and outcome, and management of complications and sequelae. […] Intravenous immunoglobulin and plasma exchange are equally effective in treating GBS; no other treatments have been proven to be effective. […] The efficacy of repeat treatment in patients who have shown insufficient clinical response is uncertain; nevertheless, this practice is common in patients who show deterioration after an initial treatment response.

• #87 Treatment guidelines for Guillain–Barré Syndrome

  https://pmc.ncbi.nlm.nih.gov/articles/PMC3152164/

  The first RCT on the use of IVIg was published in 1992, and showed that IVIg is as effective as PE. […] The combination of PE followed by IVIg was not significantly better than PE or IVIg alone. […] In general in patients with renal dysfunction the rate of infusion should be decreased to half of the normal infusion rate. […] These patients are able to walk with some support or no support. A retrospective study showed that these patients often have residual disabilities. RCTs that have assessed the effect of IVIg have not studied the effect in mildly affected patients. […] Some patients with GBS continue to deteriorate after PE or a standard course of IVIg. In these cases, the best option is unknown. […] A study in a small series of patients investigated the effect of a second course of IVIg in severe unresponsive patients with GBS. […] When faced with restrictions in financial resources, especially in developing countries cost-effectiveness of any treatment becomes a major issue in treatment decision making. This is very true in GBS in which the currently approved treatment has shown equal efficacy.

• #88 Treatment dilemmas in Guillain-Barré syndrome | Journal of Neurology, Neurosurgery & Psychiatry

  https://jnnp.bmj.com/content/88/4/346

  Current personal view: Corticosteroids as single-treatment strategy should be avoided (level of evidence: 1). […] Current personal view: We recommend repeating the treatment with IVIg or PE after a TRF, although the effect has not been determined in controlled studies (level of evidence: 4). […] Treatment of GBS is complicated by the limited amount of evidence for the treatment effect in various clinical conditions that may frequently occur in GBS.

Zobacz więcej